Gansu Fuzheng Pharmaceutical Technology Co Ltd.

To preliminarily evaluate the safety and effectiveness of the new process Zhenqi Fuzheng Capsule in improving the quality of life of patients with postoperative non-small cell lung cancer (Qi and Yin deficiency syndrome), nasopharyngeal carcinoma (Qi and Yin deficiency syndrome), and non-small cell lung cancer (Qi and Yin deficiency syndrome);